Search Results for: leon.clarke@bezosearthfund.org

More than 450 delegates attended four workshops and 20 conference sessions across four days as the ACTA International Clinical Trials Conference explored the vision of the Australian Clinical Trials Alliance: Better health…

A day of workshops provided a forum for delegates to collaborate with national and international subject matter experts on a range of topics from embedding trials to writing successful grant…

Recipient of the most prestigious award in Australian journalism, and the face of ABC Radio National’s Health Report, Dr Norman Swan will be the headline speaker at the ACTA International…

Pre-Conference Workshop: Why, when, what and how to collect economic evidence  There is a growing need among decision-makers to understand the economic and financial value of interventions, as well as the…

At the AGM, we welcomed three new Directors and celebrated a breadth of expertise that represents productive diversity We are delighted to welcome Associate Professor Rachael Morton and Ms Leonie…

…infrastructure was the third key theme identified in the report. Strong organisational structure, an organised and engaged Executive Officer, and the prioritisation of research including peer-review and trial endorsement guidelines,…

This workshop will be held on the 27–28 February 2020 in Melbourne and 5-6 March 2020 in Sydney. Presenters will include international experts A/Prof Lorenzo Trippa and Dr Steffen Ventz,…

This workshop will be held on the 27–28 February 2020 in Melbourne and 5-6 March 2020 in Sydney. Presenters will include international experts A/Prof Lorenzo Trippa and Dr Steffen Ventz,…

ACTA’s Innovative Trial Design Reference Group and STInG Leadership are heavily involved in adaptive trials and are working to ensure their professional peers can access and share their knowledge. One…

In 2018, the NHMRC released three clinical trial guidance documents under the safety reporting guidelines, which are valuable for anyone working with, conducting, or interested in best-practice clinical trials. These…

Congratulations to all who were recognised for their achievements and good works in the Australia Day honours on 26 Jan 2020. We would particularly like to acknowledge ACTA Members who…

Guidance on Implementability…

On Tuesday 11 February 2020 ACTA held its biggest webinar to date—the Super Webinar to disseminate and open communication around a guidance document ACTA has created to guide trialists towards optimising their trials for…

…good practice framework for Clinical Trial Networks and other organisations (e.g., Australian Government, funding organisations etc.) interested in setting priorities for the conduct of clinical trials. This Framework aims to…

This document will assist Clinical Trial Networks (CTNs) and other organisations that are interested in setting priorities for the conduct of clinical trials….

The slide deck used in the Implementability Super Webinar presentation which is also available in this resource area as a video recording….

ACTA held a Super Webinar in February focussed on our recently published Guidance on Implementability, which aims to provide guidance on the planning, design and conduct and reporting of clinical…

The cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study) which was posted in JAMA this…

In an article published in the American Journal of Obstetrics & Gynaecology this month, RIDSTRESS, a phase two randomised controlled trial out of the Mater Research Institute in Queensland, has…

This document will assist Clinical Trial Networks in establishing endorsement policies/guidelines….

Award guidelines and nomination form for the ACTA Trial of the Year Award 2020 including the ACTA STInG Excellence in Trial Statistics Award, and the ACTA Consumer Involvement Award. Nominations…

ACTA’s Reference Group on Research Prioritisation Tools and Criteria has developed a practical guide and good practice framework for Clinical Trial Networks (CTNs) and other organisations setting priorities for the…

One of the challenges associated with adaptive trials is ensuring that the Data Safety and Monitoring Board (DSMB) functions effectively. To help address this knowledge gap, ACTA hosted a webinar…

This document will assist Clinical Trial Networks in establishing trial endorsement policies or guidelines….

ACTA’s Reference Group on Innovative Trial Design held a webinar on the challenges associated with Data Safety and Monitoring Boards (DSMBs) in adaptive trial designs. The webinar was well received,…

Join co-hosts PRAXIS and ACTA on twitter for a short series of tweetchats focussed on COVID-19 support and information exchange for clinical trials. Use the hashtag #WhyWeDoResearch on Tuesday 28 April and…

Join co-hosts PRAXIS and ACTA on twitter for a short series of tweetchats focussed on COVID-19 support and information exchange for clinical trials. Use the hashtag #WhyWeDoResearch on Tuesday 28 April and…

While no-one can predict the broader impacts of the Covid-19 pandemic confidently, it seems likely that a sense of uncertainty will be with us for some time to come. This uncertainty will spread through…

Clinical Trials are conducted to collect the data necessary to provide information about the safety and efficacy of new treatments and interventions, that ensure that we as a society receive access to high quality,…

A two-year project to pilot the implementation of the Tele-Trial Model funded by a consortium of industry, research institutes and consumer groups with matched funding from MTPConnect commenced in August…

The Paediatric Research in Emergency Departments International Collaborative (PREDICT) is an active Clinical Trial Network that aims to investigate best approaches to emergency treatment, and to improve the care for…